+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Anti-Vascular Endothelial Growth Factor Therapeutics Market Report 2025 - Product Thumbnail Image

Anti-Vascular Endothelial Growth Factor Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Urinary Tract Infection Treatment Market Report by Product Types, Indication, End-Users, Countries and Company Analysis 2025-2033 - Product Thumbnail Image

Urinary Tract Infection Treatment Market Report by Product Types, Indication, End-Users, Countries and Company Analysis 2025-2033

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Pulmonary Drug Delivery Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Pulmonary Drug Delivery Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 96 Pages
  • Global
From
Skin Cancer Treatment Market Analysis & Forecast 2024-2034: Market By Indication; By Therapy; By Distribution Channel; and By Region - Product Thumbnail Image

Skin Cancer Treatment Market Analysis & Forecast 2024-2034: Market By Indication; By Therapy; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Opdualag (Nivolumab and Relatlimab) Drug Insight and Market Forecast - 2035 - Product Thumbnail Image

Opdualag (Nivolumab and Relatlimab) Drug Insight and Market Forecast - 2035

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Vascular Endothelial Growth Factor Receptor-2 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Endothelial Growth Factor Receptor-2 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 82 Pages
  • Global
From
HIV Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

HIV Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 99 Pages
  • Global
From
Behcet Disease Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Behcet Disease Drug Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 199 Pages
  • Global
From
Fallopian Tube Cancer Therapeutics Market 2025-2029 - Product Thumbnail Image

Fallopian Tube Cancer Therapeutics Market 2025-2029

  • Report
  • August 2025
  • 224 Pages
  • Global
From
Glioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Glioma Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 179 Pages
  • Global
From
Neuroblastoma Drugs - Global Strategic Business Report - Product Thumbnail Image

Neuroblastoma Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 263 Pages
  • Global
From
Urinary Tract Infection Treatment Market Report 2025 - Product Thumbnail Image

Urinary Tract Infection Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Glioblastoma Treatment Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Glioblastoma Treatment Drugs Market - Global Strategic Business Report

  • Report
  • February 2026
  • 287 Pages
  • Global
From
Craniopharyngioma Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Craniopharyngioma Treatment Market - Global Strategic Business Report

  • Report
  • February 2026
  • 401 Pages
  • Global
From
Malignant Glioma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Malignant Glioma Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 383 Pages
  • Global
From
Brain Tumor Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Brain Tumor Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 182 Pages
  • Global
From
Glioblastoma Multiforme Treatment Market Forecast to 2033 - Product Thumbnail Image

Glioblastoma Multiforme Treatment Market Forecast to 2033

  • Report
  • October 2025
  • 150 Pages
  • Global
From
Merkel Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Merkel Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 162 Pages
  • Global
From
HPV Associated Disorders Treatment - Global Strategic Business Report - Product Thumbnail Image

HPV Associated Disorders Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 281 Pages
  • Global
From
Loading Indicator